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Abstract
Background: Caring for patients with multimorbidity is common for generalists, although such patients are often excluded
from clinical trials, and thus such trials lack of generalizability. Data on the association between multimorbidity and
preventive care are limited. We aimed to assess whether comorbidity number, severity and type were associated with
preventive care among patients receiving care in Swiss University primary care settings.
Methods:We examined a retrospective cohort composed of a random sample of 1,002 patients aged 50–80 years attending
four Swiss university primary care settings. Multimorbidity was defined according to the literature and the Charlson index.
We assessed the quality of preventive care and cardiovascular preventive care with RAND’s Quality Assessment Tool
indicators. Aggregate scores of quality of provided care were calculated by taking into account the number of eligible
patients for each indicator.
Results: Participants (mean age 63.5 years, 44% women) had a mean of 2.6 (SD 1.9) comorbidities and 67.5% had 2 or more
comorbidities. The mean Charlson index was 1.8 (SD 1.9). Overall, participants received 69% of recommended preventive
care and 84% of cardiovascular preventive care. Quality of care was not associated with higher numbers of comorbidities,
both for preventive care and for cardiovascular preventive care. Results were similar in analyses using the Charlson index
and after adjusting for age, gender, occupation, center and number of visits. Some patients may receive less preventive care
including those with dementia (47%) and those with schizophrenia (35%).
Conclusions: In Swiss university primary care settings, two thirds of patients had 2 or more comorbidities. The receipt of
preventive and cardiovascular preventive care was not affected by comorbidity count or severity, although patients with
certain comorbidities may receive lower levels of preventive care.
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Introduction
Although caring for patients with multiple chronic conditions is
common for general internists [1,2] and an increasing burden for
healthcare systems [3], most clinical guidelines continue to use a
single-disease framework [4]. Physicians may find it difficult to
apply recommendations from clinical guidelines [5], when most of
them base their conclusions on clinical trials that exclude patients
with multimorbidity [6]. While significant resources are spent on
clinical trials, much of this acquired knowledge cannot be
translated to broader populations suffering from multiple diseases,
which may cause preventable harm due to omitted therapies,
suboptimal patient outcomes or inefficient use of resources [5]. In
addition, research on multimorbidity in primary care is limited
because of the lack of a reliable definition of multimorbidity,
explaining why its reported prevalence varies widely between 10
and 81% depending on the scores used and populations studied
[7,8].
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Concerns about the potential impact of multimorbidity on
quality of care has been noted in the past [9,10] e.g. in the context
of diabetes care [9] or psychiatric disorders [11,12]. The
increasing number of diseases with aging [2,3], the adverse effects
of polypharmacy [13], the time constraints of medical visits [2]
and the effects of comorbidities on patients’ ability to manage their
self-care [9] all seem to reduce the likelihood of high quality care
among those with multimorbidity. A higher number of comor-
bidities was indeed associated with lower provided quality of care
in six US primary care practices [14], but in the largest study of
almost 8000 US patients, Higashi et al. found that quality of care
increased with the number of comorbid diseases in three different
cohorts of patients (the CQI study, the ACOVE study and a
similarly conducted study among US Veterans) [15]. This positive
effect persisted after adjustment for confounders and the number
of visits. To further examine this controversial issue, we assessed
the association between multimorbidity and the quality of
preventive care (e.g. weight and blood pressure measurement,
alcohol consumption, and smoking cessation counseling, and
cancer screening (see Table S1) and cardiovascular preventive care
(e.g. diabetes, hypertension, dyslipidemia, see complete list in
Table S1). Instead of analyzing the overall quality of care [15], we
analyzed specific indicators of preventive care and cardiovascular
preventive care, as multimorbidity may affect predominantly these
outcomes and may deflect attention away from preventive care
more than care for chronic conditions [2]. The second aim was to
assess whether psychiatric disorders interfered with the provided
care, as suggested by others [11,12]. We hypothesized that
multimorbidity would be associated with reduced quality of
preventive care and cardiovascular preventive care, especially in
patients with psychiatric disorders.
Methods
Study Population
As previously described [16], we abstracted medical records
from a random sample of 1002 patients followed by general
internists in four Swiss university primary care settings (Basel,
Geneva, Lausanne and Zu¨rich) in a retrospective cohort study
over 2 years. The sample was randomly selected from electronic
administrative data of all patients aged 50 to 80 years followed in
2005–2006. Most patients were cared for by residents in general
internal medicine supervised by university attendings (senior
physicians), while about 10% of the patients were followed by
attendings alone. The selection was limited to this age group to
ensure sufficient prevalence of examined indicators (e.g. eligibility
for cancer screening). Briefly, among the 1889 patients identified
from electronic administrative data, 54 charts could not be found,
most likely because the patients left the clinical setting for another
practice. 591 had ,1 year follow-up in the primary care clinic
during the review period, 125 patients had no outpatient visit to a
primary care physician (PCPs) during the review period (emer-
gency visits or nurse appointments only) and 117 were followed
only in a specialized clinic. We excluded patients who were not
followed for at least 1 year to have adequate time and information
to assess provided preventive care, as previously described [16].
The final sample included 1002 abstracted medical charts.
This study was approved by the Ethics Committee of Basel, the
Human Research Ethics Committee of Geneva, the Human
Research Ethics Committee of Vaud, and the Ethics Committee of
Zu¨rich, at the sites of Basel, Geneva, Lausanne, and Zu¨rich,
respectively. Because of the retrospective cohort design, the
approving Institutional Review Boards waived the requirement
of patient consent. These data are not publicly available due to
protection of data privacy and rights of each institution on their
specific quality measurements, but data could be obtained from
the corresponding author on request.
Definition of Multimorbidity
After reviewing the literature, we found no consistent definition
or approach to guide the selection of comorbidities [17]. Others
have assessed comorbidity lists ranging from 7 different conditions
[18] to 46 [19]. We therefore derived a new list of comorbidities
based on the largest study by Higashi et al. [15] and the Charlson
index (Table S2) [20]. The Charlson index estimates the relative
risk of death from an increase of one point of the Charlson index
and is approximately equal to that from an additional 10 years of
age. A score ,3 indicates a low additional risk, whereas.6 is a
high and .8 very high risk. Additionally, we included psychiatric
conditions (e.g. schizophrenia) as an important comorbidity [21]
based on a consensus of the above mentioned references and
between the authors. The final list contains 17 important
comorbidities for ambulatory medicine (Table S3).
Definition of Quality of Preventive Care
As previously described [16], we examined 37 quality indicators
(Table S1) from the RAND’s Quality Assessment Tools related to
preventive care and to cardiovascular preventive care [22,23]. The
selection of indicators from the RAND’s Quality Assessment Tools
has been described in our previous article [16]: 14 indicators for
preventive care (e.g. physical examination, alcohol and smoking
cessation, cancer screening) and 19 for cardiovascular preventive
care (hypertension, dyslipidemia, and diabetes mellitus) and for
chronic care on coronary artery disease, as it is the most common
cause of death in Switzerland [24]. We excluded quality indicators
that were not applicable to our settings (e.g. advice to use seat-belt
is rarely performed by generalists in Switzerland), indicators that
involved information usually not routinely collected in charts in
Switzerland or adults aged 50–80 years, or indicators for
conditions of low prevalence in our sample (e.g. asthma). For
quality indicators involving a repeated assessment (e.g. HbA1c
measurement every 3 months), we checked through all consulta-
tions in the review period of 2 years to assess whether the quality
indicator was met.
Statistical Analysis
As done in other studies, for each selected indicator of
preventive care and cardiovascular preventive care, we calculated
the percentage of provided recommended care by dividing the
total number of episodes in which recommended care was
delivered by the total number of times patients were eligible for
indicators (overall percentage method) [25]. If care was refused by
eligible patients, it was considered as provided care so that
physician-initiated care was taken into account. To summarize the
selected indicators, we calculated aggregate proportions of quality
of care among the different categories of prevention (physical
examination, counseling, screening and immunization) and an
overall aggregate proportion for preventive care. The same
method of calculation was used to obtain the aggregate
proportions of chronic care for hypertension, dyslipidemia and
diabetes, and an overall aggregate proportion for chronic care for
cardiovascular risk factors, summarizing care for cardiovascular
prevention.
We used logistic mixed-effects models to derive proportions of
provided care with 95% confidence intervals, crude and adjusted
for age, sex, civil status, legal status, occupation, and treatment
center. The mixed-effects model was used to account for the
multiple assessments within patients, and for clustering of patients
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within the different treatment centers. We stratified analyses of
overall aggregate proportions according to number of comorbid-
ities and Charlson index score, and we subsequently conducted
sensitivity analyses for subgroups of high-risk patients according to
the following predefined clinical conditions: cardiovascular
disease, chronic pulmonary disease, psychiatric disorders (espe-
cially depression and schizophrenia), dementia and cancer by
comparing each group with the reference group of patients having
no comorbidity. We then calculated aggregate proportions, for all
eligible patients, and stratified according to number of comorbid-
ities (0–1 comorbidities vs $2 comorbidities). Statistical analyses
were performed with STATA release 12.1 (Stata Corp, College
Station, TX). All p-values were 2 sided.
Results
Characteristics of the Patients
Patients had a mean age of 63.5 years, 44% were women and
51% married (Table 1). 75% had hypertension, 62% dyslipidemia,
29% diabetes, while 18% were former smokers and 23% current
smokers. Patients had a median number of 10 outpatient visits
over 2 years. Regarding comorbidities, 36% had cardiovascular
diseases, 29% psychiatric disorders including depression, 26%
chronic pulmonary diseases and 14% cancer. Patients with 2 or
more chronic conditions were statistically significantly older, more
likely to be female, had more outpatient visits, more medications,
and more cardiovascular risk factors.
Multimorbidity and Quality of Preventive Care
Only 7.6% of patients had none of the 17 selected comorbidities
(Table 2), with a mean of 2.6 (SD 1.9) comorbidities per patient.
However, very few patients (2.3%) had 8 or more comorbidities.
The mean Charlson index (Table S2) [20] was 1.8 (SD 1.9),:
31.1% of patients had a index of 0, while only 1.4% had a index of
.8.
In unadjusted analyses, the global aggregate score for preventive
care was 69.2% (95% CI 60.2–76.9) and 83.9% (CI 79.3.87.7) for
cardiovascular preventive care (data not shown). The quality of
preventive care was not associated with higher numbers of
comorbidities or points of the Charlson index (Table 2). Results
were similar after adjusting for age, sex, civil status, legal status,
and occupation (Figure 1). In a sensitivity analysis, we further
adjusted for the number of outpatient visits in the previous 2 years
by performing and found similar results (data not shown).
Analysis of Specific Subgroups of Comorbidities
While quality of preventive care and cardiovascular preventive
care were comparable in patients with cardiovascular conditions,
pulmonary diseases or cancer, patients with schizophrenia or
dementia had a pattern of lower preventive care and patients with
dementia had also lower cardiovascular preventive care in
adjusted analysis (Table 2). However, the differences were not
statistically significant, likely due to the small number or patients
(schizophrenia 19, dementia 24). Rates of preventive care were not
lower for other psychiatric disorders, including depression.
Specific Quality Indicators
Patients with 2 or more chronic conditions received statistically
significantly more smoking cessation counseling (Table 3). In a
sensitivity analysis excluding patients with COPD, asthma or
cardiovascular disease, the aggregate score did not decrease with
multimorbidity (data not shown).
Discussion
Among a random sample of 1002 patients treated in Swiss
university primary care settings, we found very few patients
without one or more chronic condition, with rates comparable to
patients of similar age in other studies in primary care [26,27]. We
found high rates of preventive care (69%) and cardiovascular
preventive care (83%). The quality of preventive care and
cardiovascular preventive care was not associated with increasing
multimorbidity, either using the number of comorbidities or the
Charlson index. Patients with dementia received less preventive
care (47%), but so did those with schizophrenia (35%), although
the differences were not statistically significant.
Our study showed a comparable stable quality of preventive
care despite multimorbidity, as found by Higashi et al. [15] in the
US setting. However, several differences have to be mentioned.
First, the age distribution differed because the previous study
included many adults younger than 50 years. Second, Higashi et al.
used indicators of overall quality, while we focused on preventive
care and cardiovascular preventive care specific indicators,
assuming that multimorbidity might affect prevention first.
Similarly, Heflin et al. [28] also found no association between
multimorbidity and the receipt of cancer screening among over
2000 patients replying to a US community-based survey. Bae et al.
[29] demonstrated that diabetic patients with more chronic
conditions received better quality of preventive care among 1700
US diabetic patients and suggested this finding was accounted for
by the higher rates of outpatient visits. In our present study, results
were not confounded by the number of outpatient visits.
Some patient subgroups received less preventive care, such as
those with dementia or schizophrenia, although these differences
did not reach statistical significance. These results are consistent
with a study [11] among 113,000 US veterans showing that
patients with psychiatric disorders received less preventive care,
especially for immunization and cancer screening. Other studies
also reported the lack of cancer screening in mentally ill patients
[30–32]. In our settings, patients with dementia received less
preventive care, which might be appropriate among patients with
severe dementia who have a limited life expectancy [33].
However, in principle patients with schizophrenia should receive
the same quality of prevention as other adults. It can be speculated
that this effect might be due to a competitive issue to address all
health aspects during a time-constrained consultation. Thus,
schizophrenia could be a so dominant condition that it eclipses
other health problems, as previously described by Piette et al. [9].
This is particularly of concern for cardiovascular prevention, as
many of these patients are at increased risk for metabolic
syndrome due to treatment with antipsychotic medications [31].
Additional efforts are needed to deliver adequate preventive care
to patients with psychiatric disorders.
How can we explain the consistent high quality of preventive
care despite multimorbidity? Higashi et al. [15] proposed some
potential explanations, such as an increased use of health care in
patients with multimorbidity and the fact that adjusting data for
this increased use decreased the observed finding of higher quality
in patients with multimorbidity. However, in our study the
adjustment for the number of outpatient visits did not affect the
quality of prevention. The high quality of care could also result
from the lack of time to estimate each individual’s eligibility for
screening, to know and apply all the published guidelines, the lack
of specific guidelines for patients with multimorbidity, or the
perceived need to provide better care for older patients with
multimorbidity [34].
Multimorbidity and Quality of Care Switzerland
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Patients benefit from a universal healthcare coverage in
Switzerland. Every Swiss resident is covered by a mandatory
health insurance that covers universal healthcare, including adults
with low income who receive social aid to cover healthcare costs,
regardless of their age or whether they work. Patients are free to
choose their primary care physician (PCP). However, high quality
of care might not be fully explained by health insurance status
only; we have recently found that both forced migrants and
undocumented migrants in Switzerland had lower quality of
preventive care, albeit forced migrants have health care coverage
and undocumented migrants do not [35].
This universal healthcare coverage includes most of preventive
care services. Therefore, PCPs do not have to choose between
taking care of comorbidities or prevention for cost reasons.
However, these high rates of prevention were achieved in
Switzerland despite the lack of systematic performance monitoring
Table 1. Patient characteristics: Random sample of 1002 adults aged 50–80 years in four Swiss university primary care settings.
Characteristics Overall (n =1002) 0–1 chronic conditions (n =326) $2 chronic conditions (n=676) p-value
Age, mean (SD) 63.5 (8.3) 61.7 (8.1) 64.4 (8.2) ,0.001
Range, minimum - maximum 50–80 50–80 50–80
Women, no. (%) 445 (44.4) 166 (37.3) 279 (62.7) 0.004
Civil status, no. (% per column) 0.69
Single 151 (15.2) 54 (16.8) 97 (14.4)
Married 506 (51.0) 158 (49.2) 348 (51.8)
Divorced, separated 233 (23.5) 78 (24.3) 155 (23.1)
Widow/2er 103 (10.4) 31 (9.7) 72 (10.7)
Legal Status, no. (% per column)
Swiss 560 (55.9) 179 (57.8) 381 (58.1) ,0.001
Resident permit 325 (32.4) 89 (28.7) 236 (36.0) ,0.001
Forced migrants 81 (8.1) 42 (13.6) 39 (6.0) 0.741
Occupation, no. (% per column) ,0.001
Employed 285 (29.0) 138 (43.3) 147 (22.2)
At home or in education 115 (11.7) 31 (9.7) 84 (12.7)
Unemployed 101 (10.3) 32 (10.0) 69 (10.4)
Social aid 109 (11.1) 23 (7.2) 86 (13.0)
Retired 372 (37.9) 95 (29.8) 277 (41.8)
Number of outpatient visits over 2 years
Median (interquartile range) 10 (7–15) 8 (6–12) 12 (8–16) ,0.001
Range, minimum-maximum 2–63 2–41 3–63
Number of medications, mean (SD) 3.9 (2.7) 2.3 (1.9) 4.7 (2.7) ,0.001
Cardiovascular risk factors, no. (%)
Hypertension 753 (75.2) 158 (21.0) 595 (79.0) ,0.001
Dyslipidemia 622 (62.1) 159 (25.6) 463 (74.4) ,0.001
Diabetes 292 (29.1) 8 (2.7) 284 (97.3) ,0.001
Family history of early CHDa 99 (9.9) 33 (33.3) 66 (66.7) 0.864
Smoking status at baseline, no(%)b
Former smokers 177 (17.7) 38 (21.5) 139 (78.5) ,0.001
Current smokers 230 (23.0) 59 (25.7) 171 (74.4) 0.022
Specific subgroupsc, no. (%)
Cardiovascular diseasesd 364 (36.3) 38 (10.4) 326 (89.6) ,0.001
Psychiatric disorderse 294 (29.3) 59 (20.1) 235 (79.9) ,0.001
Chronic pulmonary diseasesf 261 (26.1) 49 (18.8) 212 (81.2) ,0.001
Cancerg 142 (14.2) 7 (4.9) 135 (67.5) ,0.001
aDefined as a coronary heart disease (CHD) event in male first-degree relatives ,55 years or in female first-degree relatives ,65 years.
bA former smoker had stopped smoking $6 months before baseline and a current smoker was smoking at baseline or had stopped,6 months before baseline.
cIf the patient has a record of ever having the listed condition or risk factor.
dHistory of transient ischemic attack, cerebral vascular accident, coronary artery disease, angina, myocardial infarction, congestive heart failure or peripheral vascular
disease.
eDepression, bipolar disorder, psychosis, schizophrenia, pervasive development disorder.
fChronic obstructive pulmonary disease (COPD), asthma, sleep apnea syndrome, sarcoidosis, pulmonary hypertension, bronchiectases, interstitial pulmonary disease or
global respiratory insufficiency.
gSolid metastatic, solid non-metastatic cancer, lymphoma, leukemia.
doi:10.1371/journal.pone.0096142.t001
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and annual report cards on quality of care, such as US Healthcare
Effectiveness Data and Information Set (HEDIS) [36,37] or of
financial incentives to improve quality.
Our study has several limitations. As previously described [16],
our data were only abstracted from medical charts with potential
underreporting; it has been found that measurements of quality of
care may be about 5% lower using abstraction of medical charts
compared to use of clinical vignettes and 10% lower compared to
use of standardized patients [38]. Additionally, we could not assess
other parameters of socio-economic status, such as income and
education, because of the lack of reliable information on these
variables in the medical charts. Our data were only abstracted in
university primary care settings, where almost all patients received
their care from residents at their end of postgraduate training.
Therefore, our data may not be generalizable to community-based
PCPs. We found only very few studies directly comparing
performance between community-based PCPs and university-
based physicians in Switzerland. One study among Swiss
community-based PCPs found similar results for diabetes care
[39]. However, we did not find other studies directly comparing
Table 2. Number of comorbidities, Charlson index and quality of preventive care and cardiovascular preventive care, analyzed also
for specific subgroups.
preventive care cardiovascular preventive care
eligible patients, no. (%) adjusteda % (CI) p-value eligible patients, no. (%) adjusteda % (CI) p-value
Comorbiditiesb
0 76 (7.6) 77.4 (65.2–86.2) 0.27c 19 (2.3) 80.9 (51.9–94.4) 0.11c
1 250 (25.0) 75.6 (63.4–84.7) 179 (21.4) 88.7 (76.3–95.0)
2 245 (24.5) 75.3 (63.1–84.5) 217 (26.0) 87.8 (74.9–94.6)
3 178 (17.8) 76.7 (64.6–85.5) 171 (20.5) 88.0 (75.1–94.7)
4 112 (11.2) 78.4 (66.6–86.8) 110 (13.2) 89.7 (78.1–95.5)
5 49 (4.9) 75.0 (61.2–85.0) 48 (5.8) 85.6 (70.0–93.8)
6 39 (3.9) 76.2 (62.9–85.9) 38 (4.5) 90.1 (78.4–95.8)
7 30 (3.0) 81.9 (70.0–89.7) 30 (3.6) 88.1 (74.0–95.1)
$8 23 (2.3) 74.8 (60.0–85.4) 23 (2.8) 93.8 (84.4–97.7)
Charlson index
0 312 (31.1) 76.9 (65.1–85.6) 0.98c 239 (28.6) 90.1 (78.8–95.7) 0.25c
1 240 (24.0) 76.0 (63.9–84.9) 178 (21.3) 87.7 (74.7–94.5)
2 159 (15.9) 76.6 (64.5–85.5) 144 (17.3) 86.6 (72.7–94.1)
3 129 (12.9) 77.6 (65.6–86.3) 124 (14.9) 89.4 (77.6–95.3)
4 76 (7.6) 77.7 (65.7–86.5) 73 (8.7) 89.3 (77.5–95.3)
5 34 (3.4) 74.9 (61.2–85.0) 34 (4.1) 88.3 (81.7–95.0)
6 26 (2.6) 79.1 (66.1–88.0) 23 (2.8) 92.3 (81.7–97.0)
7 12 (1.2) 80.2 (64.9–89.9) 7 (0.8) 89.4 (72.1–96.5)
$8 14 (1.4) 70.1 (54.0–82.5) 13 (1.6) 91.0 (78.0–96.6)
Specific subgroupsd
Cardiovascular diseasese 364 (36.3) 78.8 (61.2–89.8) 0.86f 364 (36.3) 94.1 (81.3–98.3) 0.23f
Chronic pulmonary diseasesg 261 (26.1) 78.2 (57.0–90.7) 0.84f 261 (26.1) 91.8 (68.9–98.3) 0.20f
Psychiatric disordersh 294 (29.3) 80.9 (60.6–92.1) 0.21f 294 (29.3) 79.7 (45.0–95.0) 0.64f
Depression 197 (19.7) 76.4 (49.3–91.5) 0.79f 197 (19.7) 73.2 (26.8–95.3) 0.32f
Schizophreniai 19 (1.9) 35.1 (5.7–82.9) 0.44f 19 (1.9) 75.8 (0.0–100.0) 0.52f
Dementia 24 (2.4) 46.8 (8.7–89.0) 0.73f 24 (2.4) 17.3 (0.0–99.2) 0.97f
Cancerj,k 142 (14.2) 76.1 (46.3–92.1) 0.77f 142 (14.2) 96.7 (74.2–99.7) 0.32f
aData adjusted for these patients characteristics: age, sex, civil status, legal status, occupation and center. In a 2nd model we adjusted also for the number of outpatient
visits by performing a Sensitivity analyses, which showed similar results.
bBased on previous studies[16] and the Charlson index [20].
cp for trend.
dIf the patient has a record of ever having the listed condition or risk factor.
eHistory of transient ischemic attack, cerebral vascular accident, coronary artery disease, angina, myocardial infarction, congestive heart failure or peripheral vascular
disease.
fp-value comparing adjusted data for each subgroup to patients with 0 comorbidities.
gChronic obstructive pulmonary disease (COPD), asthma, sleep apnea syndrome, sarcoidosis, pulmonary hypertension, bronchiectases, interstitial pulmonary disease or
global respiratory insufficiency.
hDepression, bipolar disorder, psychosis, schizophrenia, pervasive development disorder.
iNot further adjusted for legal status because of low number of patients with data on legal status (n = 10 of 19 patients with schizophrenia).
jSolid metastatic, solid non-metastatic cancer, lymphoma, leukemia.
kLower care when metastatic cancer only (data not shown, due to small number of 16 patients).
doi:10.1371/journal.pone.0096142.t002
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overall performance between community-based PCPs and univer-
sity-based physicians. Lastly, the prevalence of some comorbidities
may be higher in our population than in community-based PCPs,
such as for hypertension (75%). However, multimorbidity is also
an increasing burden for community-based PCPs [40,41].
Conclusions
In summary, multimorbidity is very common in Swiss university
primary care settings, as well as for community-based practice[41].
Quality of preventive care and cardiovascular preventive care
remains high regardless of increasing number of comorbidities.
There was a pattern of appropriately lower prevention among
patients with dementia. This was also found in schizophrenic
patients, a population that should receive the same preventive care
Figure 1. Measures of multimorbidity and association with quality of preventive care. Left part: Number of comorbidities and percent of
provided care for preventive care (blue line) and cardiovascular preventive care (red line), bars showing 95% confidence intervals. Right part:
Respective analysis with the Charlson index. Data adjusted for age, sex, civil status, legal status, occupation and treatment center. In a second model
we adjusted for number outpatient visits and found similar results.
doi:10.1371/journal.pone.0096142.g001
Table 3. Adjusted aggregate scores of provided as recommended preventive care and cardiovascular preventive carea: adjusted
dataa.
Aggregate scores, % (CI) Overallb, % (CI) 0–1 comorbidities, % (CI) $2 comorbidities, % (CI) p-value
Physical examination 97.9 (92.3–99.5) 97.8 (91.7–99.4) 98.3 (93.3–99.7) 0.07
Alcohol consumption counseling 90.6(43.3–99.2) 90.2(42.2–99.1) 91.4 (45.2–99.3) 0.56
Smoking cessation counseling 72.8 (35.5–92.9) 69.6 (32.5–91.6) 78.1 (42.5–94.5) 0.006
Cancer screening 61.4 (26.4–87.6) 62.5 (27.2–88.1) 59.5 (24.6–86.8) 0.39
Global aggregate score for preventive care 76.4 (64.6–85.2) 76.2 (64.5–85.1) 76.7 (64.9–85.4) 0.67
Diabetes mellitus 80.7 (53.2–93.1) 78.0 (46.8–93.5) 81.5 (54.2–94.3) 0.52
Hypertension 91.3 (75.9–97.2) 90.6 (74.0–97.0) 92.0 (77.3–97.5) 0.20
Dyslipidemia 95.2 (7.1–100) 92.2 (3.6–100) 96.8 (8.7–100) 0.06
Global aggregate score for cardiovascular preventive
carec
88.6 (76.3–94.9) 88.6 (76.2–95.0) 88.6 (76.2–94.9) 0.97
aData were adjusted for age, sex, civil status, legal status, occupation and treatment center. In a second model we adjusted also for the number of outpatient visits by
performing a sensitivity analyses and found similar results. Detailed numbers for each indicator are provided in the Table 2 by Collet et al [16].
bIf care was refused by eligible patients, it was counted as provided care to measure physician-initiated care. When care was provided less frequently than specified (i.e.,
once a year instead of twice a year or only once instead of annually), it was counted as unprovided care to measure physician adherence to recommendations.
cWhen care was contraindicated, the patient was not counted as eligible, thus reducing the denominator.
doi:10.1371/journal.pone.0096142.t003
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as other healthy adults. Additional efforts should be done to
implement adequate preventive care for patients with psychiatric
disorders.
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